Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a uniqueness pharmaceutical company that emerges and distributes recipe medical food products to actually physicians, pharmacies and skilled nursing fixtures, posted achievements from a clinical trial of the company's valuable medical food products TheramineÂ. The trial confirmed development in chronic lower back pain in 129 elements when administered being a standalone therapy or in conjunction along with low concentration naproxen for 28 days.
"This research shows that Theramine is an effective and safe treatment for pain and irritation linked to chronic back pain without the concern of gastrointestinal hemorrhage or other serious negative effects such as hypertension," said David Silver, M.D., co-author of most study and executive vice chairman of medical and scientific relationships at Targeted Medical Pharma, Inc.
In the whole study that was completed in 2009 topics underwent baseline screening, informed consent and an initial screening survey. On weekly basis, subjects could repeat finishing of the endpoint measures. At baseline and day 28, blood samples were really gathered from each patient. The leading endpoint was lowering of the subject's perception of their total chronic low back pain. Secondary endpoints were really measured by evaluating the subject's baseline and day 28 blood samples, in addition to reports of rescue drugs implemented and additional performance scales.
No comments:
Post a Comment